Skip to main content
PhRMA LogoPhRMA logo with words Research, Progress, and Hope underneath
  • Our Network
    Voters for Cures Logo

    Make your voice heard. Join us in our mission to support medical progress and policies that make new medicines possible.

    Learn More
    America's Biopharmaceutical Companies Logo

    Learn more about America's biopharmaceutical companies and how they seek to improve patients' lives.

    Learn More
    Medicine Assistance Tool Logo

    A search engine designed to find resources available through the various biopharmaceutical industry programs.

    Learn More
    Let's Talk About Cost Logo

    Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

    Learn More
    Prescription for Medicare Logo

    There are right and wrong prescriptions for changing Medicare. Seniors need Washington to focus on the right ones.

    Learn More
    PhRMA Foundation Logo

    The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

    Learn More
    We Work For Health Logo

    We Work For Health aims to increase awareness by uniting workers throughout the industry.

    Learn More
  • Members Site
  • Press Room
  • Events
  • Stay Connected

    Stay Connected

    Sign Up for Updates

  • Search the PhRMA Network

PhRMA LogoPhRMA logo with words Research, Progress, and Hope underneath
  • About
    Overview Our Mission Our Leadership Members Careers Events Codes & Guidelines

    About

    PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures.

    PhRMA Commitment to Equity
    Industry Profile 2020
  • Advocacy
    Overview
    Access to Medicines
    Overview Insurance Coverage Medicare Patient Assistance Medicaid 340B Drug Pricing Program
    Cost & Value of Medicines
    Let's Talk About Cost Discounts
    International Intellectual Property
    Medicare
    Overview Part B Part D Center for Medicare and Medicaid Innovation
    Medicine Safety
    Overview Prescription Drug Misuse, Abuse & Disposal Drug Importation Drug Shortages
    Research & Development
    Overview Biologics & Biosimilars Clinical Trials Manufacturing and Supply Chain Venture Capital FDA Modernization PDUFA Pediatrics Rare Diseases Regulatory Harmonization Vaccines
    The Value Collaborative 340B

    Advocacy

    From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.

    340B | PhRMA
    Part B | PhRMA
  • Science
    Overview Progress Treating Disease
    In The Pipeline
    Overview Medicines in Development Research in your Backyard Clinical Trials
    People Behind the Science

    Science

    Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science.

    The 20-year journey yielding a new weapon against cancer | PhRMA
    The Latest on the Biopharmaceutical Industry's Efforts to Beat Coronavirus | PhRMA
  • Patients
    Overview How Are Your Medicines Covered? Get Help With Your Prescriptions Access Patient Resources

    Patients

    Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments.

    Share the Savings | PhRMA
    Patient-Focused Drug Development | PhRMA
  • Resources
    State Map Press Room Resource Library Chart Packs Industry Profile 2020

    Resources

    Explore the Resource Library, the interactive State Map and the Chart Pack reports.

    Press Room | PhRMA
    Chart Packs | PhRMA
  • Blog
  • About
    Back

    About

    PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures.

    Overview Our Mission Our Leadership Members Careers Events Codes & Guidelines
  • Advocacy
    Back

    Advocacy

    From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.

    Overview Access to Medicines
    Overview Insurance Coverage Medicare Patient Assistance Medicaid 340B Drug Pricing Program
    Cost & Value of Medicines
    Overview Let's Talk About Cost Discounts
    International Intellectual Property Medicare
    Overview Part B Part D Center for Medicare and Medicaid Innovation
    Medicine Safety
    Overview Prescription Drug Misuse, Abuse & Disposal Drug Importation Drug Shortages
    Research & Development
    Overview Biologics & Biosimilars Clinical Trials Manufacturing and Supply Chain Venture Capital FDA Modernization PDUFA Pediatrics Rare Diseases Regulatory Harmonization Vaccines
    The Value Collaborative 340B
  • Science
    Back

    Science

    Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science.

    Overview Progress Treating Disease In The Pipeline
    Overview Medicines in Development Research in your Backyard Clinical Trials
    People Behind the Science
  • Patients
    Back

    Patients

    Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments.

    Overview How Are Your Medicines Covered? Get Help With Your Prescriptions Access Patient Resources
  • Resources
    Back

    Resources

    Explore the Resource Library, the interactive State Map and the Chart Pack reports.

    Overview State Map Press Room Resource Library Chart Packs Industry Profile 2020
  • Blog
  • Our Network
    Back
    Voters for Cures Logo

    Make your voice heard. Join us in our mission to support medical progress and policies that make new medicines possible.

    Learn More
    America's Biopharmaceutical Companies Logo

    Learn more about America's biopharmaceutical companies and how they seek to improve patients' lives.

    Learn More
    Medicine Assistance Tool Logo

    A search engine designed to find resources available through the various biopharmaceutical industry programs.

    Learn More
    Let's Talk About Cost Logo

    Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

    Learn More
    Prescription for Medicare Logo

    There are right and wrong prescriptions for changing Medicare. Seniors need Washington to focus on the right ones.

    Learn More
    PhRMA Foundation Logo

    The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

    Learn More
    We Work For Health Logo

    We Work For Health aims to increase awareness by uniting workers throughout the industry.

    Learn More
  • Members Site
  • Press Room
  • Events
  • Stay Connected
    Back

    Stay Connected

    Sign Up for Updates

+Share This

Share This

RESEARCH & DEVELOPMENT

FDA Modernization

The United States leads the world in the introduction of new medicines thanks in part to the human drug review program by the U.S. Food and Drug Administration (FDA). To ensure the Agency keeps pace with scientific discovery and to enable a more competitive, innovative and sustainable ecosystem, we need to modernize the FDA.

Pro-patient, pro-science, pro-market reforms at the FDA would enhance the competitive market for biopharmaceuticals, drive efficiency in drug development and discovery and help hold down costs. PhRMA suggests policy solutions in three areas for modernizing drug discovery, development and approval:

Encourage Use of 21st Century Tools for Drug Evaluation, Review and Approval

Scientific advances are re-shaping our understanding of the causes of disease, creating new avenues of research, exploration and discovery. New and powerful tools emphasize individual patient characteristics and include innovative clinical trial design, advanced statistical methods and use of real-world evidence.

-

SOLUTIONS

Ensure FDA Drug Approval Is Scientifically Sound and Efficient

Medical and basic science is advancing at a breathtaking rate. New developments – including those in immunologic and cell therapies, personalized medicine and regenerative medicine – hold the promise of treating debilitating diseases such as Alzheimer’s, cancer, diabetes and many rare disorders.

-

SOLUTIONS

Reduce the Generic Backlog and Incentivize Competition Where Needed

A generic drug enters the market at the end of an innovative medication’s lifecycle. When it does, the FDA allows the manufacturer to submit an Abbreviated New Drug Application (ANDA), which does not require repetition of time consuming and costly clinical trials. As a result, generics can enter the market at a fraction of the price of an innovator medicine. With nearly 91 percent of all U.S. retail prescriptions filled with generics, their timely approval is critical to patient access and the long-term sustainability of our health care system.

-

SOLUTIONS

-

Policy Paper

Policy Solutions

-

Graphic

The Dangers of Drug Importation: Counterfeit Cancer Drugs

default_1000x635_press-release

-

Press release

Statement on Workforce Authorities Modernization Act

Related Content

Biologics & Biosimilars | PhRMA

from phrma

Read More

Regulatory Harmonization | PhRMA

from phrma

Read More
Medicine Safety

Medicine Safety | PhRMA

from phrma

Read More

Clinical Trials | PhRMA

from phrma

Read More

Latest From The

Blog

  • Election insights: Common ground areas to address Americans’ health care concerns

    by Mark Keida on 1/26/2021 4:30:56 PM

  • 2020 FDA approvals show innovation despite COVID-19 pandemic challenges

    by Andrew Powaleny on 1/26/2021 2:00:00 PM

  • New insulin report highlights how incentives benefit middlemen, harm patients

    by Brian Newell on 1/22/2021 2:33:41 PM

  • Key facts: The final rebate rule will be a positive change for patients

    by Tom Wilbur on 1/19/2021 2:26:28 PM

Stay

Connected

The Voters for Cures logo - Voters for Cures - an initiative from PhRMA
ABCStacked
Medicine Assistance Tool
Let's Talk About Cost
My old Meds
PhRMA Foundation
We Work for Health

  • MEMBERS SITE
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Site Map

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."